What this topic covers
CD19 CAR-T papers often cover diffuse large B-cell lymphoma, acute lymphoblastic leukemia, B-cell aplasia, antigen-negative relapse, manufacturing, and emerging autoimmune indications.
Topic feed
Recent CD19 CAR-T Papers
Track CD19-directed CAR-T research across lymphoma, leukemia, autoimmune disease, B-cell depletion, resistance, and long-term clinical follow-up.
How to use this feed
Search CD19 CAR-T broadly first, then refine with lymphoma, leukemia, lupus, autoimmune disease, relapse, ICANS, CRS, or long-term follow-up.
Search ideas
Useful searches to try next
Research context
How to read this topic
What makes this topic active?
CD19 remains one of the most studied CAR-T targets, with ongoing research in hematologic malignancies and expanding autoimmune disease use.
Which filters help?
The published-paper filter is useful for clinical outcomes; preprints can help catch emerging immunology and engineering work earlier.